Filip Janku - Jun 23, 2021 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Chief Medical Officer
Signature
/s/ Ajim Tamboli, Attorney-in-Fact
Stock symbol
GLUE
Transactions as of
Jun 23, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 05:00 PM
Next filing
Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Stock Option (Right to Buy) Award $0 +387K $0.00 387K Jun 23, 2021 Common Stock 387K $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on June 1, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.